A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

December 31, 2018

Conditions

Rash Due to Epidermal Growth Factor Receptor Inhibitors

Interventions

DRUG

RECONVAL CREAM

DRUG

PLACEBO

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER

NCT01763307 - A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI | Biotech Hunter | Biotech Hunter